Header Logo

Mayra Tisminetzky

Concepts (169)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
21
2022
862
4.840
Why?
Multiple Chronic Conditions
6
2023
37
3.790
Why?
Heart Failure
12
2023
853
3.050
Why?
Patient Readmission
7
2021
421
1.600
Why?
Multimorbidity
7
2025
43
1.500
Why?
Acute Coronary Syndrome
4
2017
250
1.430
Why?
Hospitalization
13
2022
1293
1.430
Why?
Atrial Fibrillation
9
2022
806
1.410
Why?
Chronic Disease
6
2025
717
1.210
Why?
Aged
34
2025
13423
1.020
Why?
Inpatients
3
2019
292
1.010
Why?
Survivors
2
2017
150
1.000
Why?
Diabetes Mellitus
3
2022
515
0.950
Why?
Angiotensin Receptor Antagonists
4
2022
64
0.870
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2022
142
0.850
Why?
Hospital Mortality
8
2018
845
0.810
Why?
Hyperkalemia
1
2022
20
0.800
Why?
Male
39
2025
27794
0.790
Why?
Massachusetts
16
2021
2023
0.780
Why?
Retrospective Studies
15
2023
6085
0.770
Why?
Aged, 80 and over
16
2023
5125
0.760
Why?
Percutaneous Coronary Intervention
4
2022
160
0.760
Why?
Age Factors
9
2021
1504
0.740
Why?
Electrocardiography
2
2015
524
0.740
Why?
Female
38
2025
30779
0.700
Why?
Acute Kidney Injury
1
2022
132
0.700
Why?
Risk Factors
15
2022
4991
0.690
Why?
Mobility Limitation
1
2020
47
0.680
Why?
Morbidity
1
2020
113
0.680
Why?
Chest Pain
2
2020
81
0.660
Why?
Humans
44
2025
59476
0.620
Why?
Independent Living
1
2018
44
0.590
Why?
Risk Assessment
7
2022
1927
0.590
Why?
Anemia
1
2019
119
0.590
Why?
Disease Management
1
2019
220
0.560
Why?
Middle Aged
20
2025
16339
0.560
Why?
Adrenergic beta-Antagonists
2
2017
147
0.550
Why?
Length of Stay
7
2017
779
0.540
Why?
Time Factors
10
2019
3619
0.520
Why?
Psychosocial Deprivation
1
2015
8
0.510
Why?
Research
1
2017
187
0.500
Why?
Patient Acceptance of Health Care
1
2020
454
0.490
Why?
Survival Rate
5
2019
801
0.470
Why?
Cardiac Catheterization
2
2022
253
0.460
Why?
Patient Discharge
6
2017
492
0.450
Why?
Follow-Up Studies
6
2019
2341
0.450
Why?
Quality of Life
6
2022
1138
0.440
Why?
Myocardial Revascularization
1
2014
71
0.430
Why?
Diabetes Complications
1
2014
100
0.420
Why?
Secondary Prevention
1
2014
153
0.410
Why?
Delivery of Health Care
1
2017
413
0.410
Why?
Forecasting
1
2014
221
0.410
Why?
Primary Prevention
1
2014
134
0.400
Why?
Platelet Aggregation Inhibitors
1
2014
211
0.390
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
208
0.380
Why?
Comorbidity
6
2020
1080
0.360
Why?
Multivariate Analysis
4
2017
903
0.360
Why?
Sex Factors
6
2020
938
0.360
Why?
Anxiety
2
2020
387
0.340
Why?
Treatment Outcome
8
2017
5293
0.310
Why?
Frailty
2
2022
124
0.310
Why?
Anxiety Disorders
1
2011
187
0.310
Why?
Caregivers
2
2025
232
0.310
Why?
Cardiovascular Diseases
1
2016
789
0.310
Why?
Chi-Square Distribution
4
2017
409
0.300
Why?
Stroke
4
2022
1133
0.300
Why?
Depressive Disorder, Major
1
2011
250
0.290
Why?
Cause of Death
2
2019
210
0.290
Why?
United States
5
2025
7431
0.280
Why?
Depression
2
2020
830
0.260
Why?
Coronary Artery Bypass
3
2022
275
0.250
Why?
Prognosis
5
2017
1598
0.230
Why?
Cohort Studies
5
2018
2377
0.220
Why?
Prevalence
2
2019
1257
0.220
Why?
Potassium
1
2022
101
0.190
Why?
Medical Records, Problem-Oriented
1
2021
13
0.180
Why?
Adult
7
2025
15704
0.180
Why?
Parents
1
2025
367
0.180
Why?
Early Detection of Cancer
1
2024
267
0.180
Why?
Sleep Apnea, Obstructive
1
2022
54
0.180
Why?
Colorectal Neoplasms
1
2024
263
0.180
Why?
Anticoagulants
2
2022
479
0.170
Why?
Needs Assessment
1
2021
187
0.170
Why?
Frail Elderly
1
2020
107
0.160
Why?
Hemorrhage
1
2021
259
0.160
Why?
Antiviral Agents
1
2022
312
0.160
Why?
Adaptation, Psychological
2
2012
261
0.160
Why?
Musculoskeletal Diseases
1
2020
101
0.160
Why?
Osteoarthritis
1
2020
131
0.150
Why?
Prospective Studies
4
2022
3072
0.150
Why?
Incidence
3
2018
1239
0.140
Why?
Logistic Models
3
2016
1237
0.140
Why?
Disease-Free Survival
1
2017
228
0.140
Why?
Drug Interactions
1
2017
115
0.140
Why?
Surveys and Questionnaires
3
2022
2516
0.130
Why?
Patient Care Management
1
2016
30
0.130
Why?
Renal Insufficiency, Chronic
1
2017
114
0.130
Why?
Lung Diseases
1
2017
170
0.130
Why?
Patient Outcome Assessment
1
2016
52
0.130
Why?
Health Services Research
1
2017
266
0.120
Why?
Georgia
1
2015
87
0.120
Why?
Hypolipidemic Agents
1
2015
25
0.120
Why?
Diuretics
1
2015
59
0.120
Why?
Calcium Channel Blockers
1
2015
57
0.120
Why?
Multicenter Studies as Topic
1
2015
130
0.120
Why?
Electronic Health Records
1
2018
342
0.120
Why?
Self Report
3
2022
359
0.120
Why?
Health Status
1
2017
426
0.120
Why?
Aging
1
2020
710
0.110
Why?
Stroke Volume
1
2015
314
0.110
Why?
Longitudinal Studies
1
2017
1188
0.110
Why?
Personality Inventory
2
2011
54
0.100
Why?
Academic Medical Centers
1
2015
309
0.100
Why?
Aspirin
1
2014
167
0.100
Why?
Predictive Value of Tests
1
2015
1029
0.100
Why?
Cooperative Behavior
1
2013
210
0.090
Why?
Models, Psychological
1
2012
94
0.090
Why?
Cross-Sectional Studies
2
2025
2383
0.090
Why?
Case-Control Studies
1
2014
1057
0.090
Why?
Angina, Unstable
1
2011
57
0.090
Why?
Pediatrics
1
2013
241
0.090
Why?
Psychiatric Status Rating Scales
1
2012
382
0.090
Why?
Fear
1
2011
64
0.090
Why?
Body Mass Index
1
2014
832
0.080
Why?
Mental Health Services
1
2013
269
0.080
Why?
Severity of Illness Index
1
2015
1483
0.080
Why?
Health Services Accessibility
1
2013
527
0.080
Why?
Sex Distribution
2
2018
244
0.070
Why?
Age Distribution
2
2018
250
0.070
Why?
Geriatric Assessment
2
2020
158
0.070
Why?
Behavioral Risk Factor Surveillance System
1
2024
43
0.050
Why?
Health Surveys
1
2025
299
0.050
Why?
Monoamine Oxidase Inhibitors
1
2002
10
0.050
Why?
Antidepressive Agents, Tricyclic
1
2002
19
0.050
Why?
Fluoxetine
1
2002
44
0.050
Why?
Odds Ratio
2
2015
748
0.050
Why?
Acute Disease
2
2015
660
0.050
Why?
Perception
1
2022
168
0.050
Why?
Antidepressive Agents
1
2002
213
0.050
Why?
Patient Reported Outcome Measures
1
2021
127
0.040
Why?
Depressive Disorder
1
2002
279
0.040
Why?
Activities of Daily Living
1
2020
288
0.040
Why?
Cognition
1
2022
455
0.040
Why?
Social Support
1
2020
355
0.040
Why?
Patient-Centered Care
1
2020
246
0.030
Why?
Urban Health
1
2015
40
0.030
Why?
Cardiotonic Agents
1
2015
50
0.030
Why?
Exercise
1
2022
883
0.030
Why?
Young Adult
1
2025
4277
0.030
Why?
Shock, Cardiogenic
1
2015
86
0.030
Why?
Confidence Intervals
1
2013
242
0.030
Why?
Checklist
1
2013
72
0.030
Why?
Analysis of Variance
1
2013
591
0.020
Why?
Survival Analysis
1
2013
554
0.020
Why?
Proportional Hazards Models
1
2013
674
0.020
Why?
Guideline Adherence
1
2013
296
0.020
Why?
Edema
1
2010
42
0.020
Why?
Dyspnea
1
2010
116
0.020
Why?
Health Care Surveys
1
2010
279
0.020
Why?
Practice Guidelines as Topic
1
2013
706
0.020
Why?
Adolescent
2
2013
5854
0.020
Why?
Cough
1
2010
183
0.020
Why?
Mass Screening
1
2013
649
0.020
Why?
Practice Patterns, Physicians'
1
2010
693
0.010
Why?
Child
1
2013
4205
0.010
Why?
Postmenopause
1
2002
224
0.010
Why?
Dose-Response Relationship, Drug
1
2002
805
0.010
Why?
Double-Blind Method
1
2002
713
0.010
Why?
Randomized Controlled Trials as Topic
1
2002
678
0.010
Why?
Tisminetzky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (169)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_